Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Nature Communications|August 7, 2015
MEF2B mutations in non-Hodgkin lymphoma dysregulate cell migration by decreasing MEF2B target gene activationJulia R Pon, Jackson Wong, Saeed Saberi, et al.
Molecular and Cellular Biology|September 19, 2012
Interaction of cyclin-dependent kinase 12/CrkRS with cyclin K1 is required for the phosphorylation of the C-terminal domain of RNA polymerase IIS-W Grace Cheng, Michael A Kuzyk, Annie Moradian, et al.
Plos One|December 20, 2022
A pragmatic parallel arm randomized-controlled trial of a multi-pronged electronic health record-based clinical decision support tool protocol to reduce low-value antipsychotic prescriptions among older adults with Alzheimer's and related dementiasJohn N Mafi, Anne M Walling, Chad Villaflores, et al.
Plos One|December 5, 2024
Correction: A pragmatic parallel arm randomized-controlled trial of a multi-pronged electronic health record-based clinical decision support tool protocol to reduce low-value antipsychotic prescriptions among older adults with Alzheimer's and related dementiasJohn N Mafi, Anne M Walling, Chad Villaflores, et al.
BMC Pediatrics|November 11, 2022
Utility of illness symptoms for predicting COVID-19 infections in childrenGeena Y Zhou, Nicole Y Penwill, Grace Cheng, et al.
Diabetes Care|September 28, 2023
The Effectiveness of Shared Decision-making for Diabetes Prevention: 24- and 36-Month Results From the Prediabetes Informed Decision and Education (PRIDE) TrialO Kenrik Duru, Carol M Mangione, Norman Turk, et al.
The Journal of Pathology|June 3, 2015
Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesisJiamin Chen, Yemin Wang, Melissa K McMonechy, et al.
Nucleic Acids Research|March 24, 2017
CDK12 regulates alternative last exon mRNA splicing and promotes breast cancer cell invasionJerry F Tien, Alborz Mazloomian, S-W Grace Cheng, et al.
Blood|December 31, 2010
Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylationDamian B Yap, Justin Chu, Tobias Berg, et al.
EMBO Molecular Medicine|March 6, 2020
Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemiaBai-Liang He, Ning Yang, Cheuk Him Man, et al.
Pageof 3